Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
intermittent claudication/krvarenje
Veza se sprema u međuspremnik
Stranica 1 iz 130 rezultatima
[High blood pressure as cause of intermittent claudication and cerebral hemorrhage].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Hemorrhagic lumbar facet cysts accompanying a spinal subdural hematoma at the same level.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND
We present a rare and interesting case of hemorrhagic lumbar facet cysts accompanying a spinal subdural hematoma at the same level suggesting a possible mechanism by which spinal subdural hematomas can arise.
RESULTS
A 71-year-old man presented with persistent sciatic pain and
Lethal hemorrhage caused by aortoenteric fistula following endovascular stent implantation.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
A 55-year-old women developed an aortointestinal fistula between the bifurcation of the aorta and the distal ileum following implantation of multiple endovascular stents into both common iliac arteries for treatment of aortoiliac occlusive disease. Ten months before the acute onset of the
Interspinous process implantation for the treatment of neurogenic intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND
Lumbar spinal stenosis (LSS) is a disabling medical condition in which narrowing of the spinal canal compresses the spinal cord and nerves causing a condition called neurogenic intermittent claudication (NIC). Decompressive spine surgery is the standard of care for patients who fail to
Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE
Patients with lower-extremity peripheral arterial disease (PAD) face a high risk of cardiovascular morbidity and mortality. Platelet inhibition (PI) significantly reduces this risk. Combination PI is common and increasingly indicated in patients with PAD; however, the effect on platelet
Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
(1) Intermittent claudication is usually a sign of generalised vascular atheroma, with prognosis mainly depending on the degree of coronary and cerebral involvement. Treatment is based on smoking cessation and regular exercise. Vasodilators have a purely symptomatic effect, modest at best, in
[Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Cilostazol, a selective inhibitor of phosphodiesterase III, is an antiplatelet drug and a vasodilator via increased cAMP levels. It has been approved for the treatment of ischemic symptoms in chronic peripheral arterial obstruction or intermittent claudication and for secondary prevention of
Variability in responsiveness to clopidogrel in patients with intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE
The concept of clopidogrel resistance is frequently evoked in the cardiac literature. The variability of antiplatelet response in patients with intermittent claudication has not been investigated. The aim of this study was to describe the effect of the addition of clopidogrel to aspirin
Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The efficacy and safety of pentoxifylline (400 mg tid orally) and acenocoumarol, administered singly or in combination, in the treatment of intermittent claudication associated with chronic occlusive arterial disease were evaluated in a multi-center, randomized, factorial, blind clinical trial
Efficacy of low-molecular-weight heparin in the management of intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Treating chronic arterial occlusive disease with heparin is controversial because of the risks associated with long-term anticoagulant therapy. Low molecular weight (LMW) heparin (mw about 5000 Dalton), which selectively inhibits the Xa factor with minimal risk of hemorrhage, seems to offer new
Risk, types, and severity of intracranial hemorrhage in patients with symptomatic carotid artery stenosis.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE
We sought to report the occurrence and risk factors of intracranial hemorrhage during long-term follow-up of patients with internal carotid artery stenosis, with and without carotid endarterectomy.
METHODS
From the prospective data of the North American Symptomatic Carotid Endarterectomy
Lack of effect of a 24-hour infusion of iloprost in intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
24 hour infusion of iloprost was compared with placebo infusion in 19 patients with stable intermittent claudication using a double blind, balanced crossover design. Despite significant inhibition of platelet aggregation to ADP and collagen (p less than 0.001) and the typical cardiovascular and
Clinical efficacy of picotamide in long-term treatment of intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The clinical efficacy of picotamide was investigated in a randomized, double-blind, placebo-controlled study in patients with peripheral occlusive arterial disease of the lower limbs at functional stage II of the Fontaine classification. Forty patients with a history of claudication for at least six
The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
After a 1-month placebo run-in phase, 27 patients with proven peripheral arterial obstructive disease participated in a double blind placebo controlled study and were divided in 3 groups, receiving either placebo, ridogrel 300 mg b.i.d. (a combined thromboxane synthase and receptor blocking agent)
Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE
The purpose of this study was to investigate whether cilostazol reduces restenosis and revascularization after endovascular therapy (EVT) for femoropopliteal lesions.
BACKGROUND
Cilostazol improves walking distance in patients with intermittent claudication and reduces restenosis after
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
